XML 46 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation (Table)
12 Months Ended
Oct. 31, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense and the Resulting Tax Benefits
Stock-based compensation expense and the resulting tax benefits for operations were as follows:
 For the fiscal years ended October 31
 202020192018
 In millions
Stock-based compensation expense$278 $297 $268 
Income tax benefit(48)(47)(59)
Stock-based compensation expense, net of tax$230 $250 $209 
Weighted-Average Fair Value and Assumptions Used to Measure Fair Value of Restricted Stock Units HP uses the closing stock price on the grant date to estimate the fair value of service-based restricted stock units. HP estimates the fair value of restricted stock units subject to performance-adjusted vesting conditions using a combination of the closing stock price on the grant date and the Monte Carlo simulation model. The assumptions used to measure the fair value of restricted stock units subject to performance-adjusted vesting conditions in the Monte Carlo simulation model were as follows:
 For the fiscal years ended October 31
 202020192018
Expected volatility(1)
27.6 %26.5 %29.5 %
Risk-free interest rate(2)
1.6 %2.7 %1.9 %
Expected performance period in years(3)
2.92.92.9
(1)The expected volatility was estimated using the historical volatility derived from HP’s common stock.
(2)The risk-free interest rate was estimated based on the yield on U.S. Treasury zero-coupon issues.
(3)The expected performance period was estimated based on the length of the remaining performance period from the grant date.
Summary of Restricted Stock Awards Activity
A summary of restricted stock units activity is as follows:
 As of October 31
 202020192018
 SharesWeighted-
Average
Grant Date
Fair Value
Per Share
SharesWeighted-
Average
Grant Date
Fair Value
Per Share
SharesWeighted-
Average
Grant Date
Fair Value
Per Share
 In thousands In thousands In thousands 
Outstanding at beginning of year29,960 $21 30,784 $18 31,822 $14 
Granted18,109 $20 17,216 $22 16,364 $21 
Vested(14,929)$20 (16,934)$16 (15,339)$15 
Forfeited(3,309)$21 (1,106)$20 (2,063)$17 
Outstanding at end of year29,831 $21 29,960 $21 30,784 $18 
Weighted-Average Fair Value and Assumptions Used to Measure Fair Value of Stock Options
HP utilizes the Black-Scholes-Merton option pricing formula to estimate the fair value of stock options subject to service-based vesting conditions. HP estimates the fair value of stock options subject to performance-contingent vesting conditions using a combination of a Monte Carlo simulation model and a lattice model as these awards contain market conditions. The weighted-average fair value and the assumptions used to measure fair value were as follows:
 For the fiscal years ended October 31
 202020192018
Weighted-average fair value(1)
$$$
Expected volatility(2)
29.8 %29.8 %29.4 %
Risk-free interest rate(3)
1.6 %1.7 %2.5 %
Expected dividend yield(4)
4.0 %3.7 %2.6 %
Expected term in years(5)
6.06.05.0
(1)The weighted-average fair value was based on stock options granted during the period.
(2)Expected volatility was estimated based on a blended volatility (50% historical volatility and 50% implied volatility from traded options on HP's common stock).
(3)The risk-free interest rate was estimated based on the yield on U.S. Treasury zero-coupon issues.
(4)The expected dividend yield represents a constant dividend yield applied for the duration of the expected term of the award.
(5)For awards subject to service-based vesting, the expected term was estimated using a simplified method; and for performance-contingent awards, the expected term represents an output from the lattice model
Summary of Stock Options Activity
A summary of stock options activity is as follows:
 As of October 31
 202020192018
 SharesWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
SharesWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
SharesWeighted-
Average
Exercise
Price
Weighted-
Average
Remaining
Contractual
Term
Aggregate
Intrinsic
Value
 In
thousands
 In yearsIn
millions
In
thousands
 In yearsIn
millions
In
thousands
 In yearsIn
millions
Outstanding at beginning of year7,093 $16   7,086 $14   18,067 $13   
Granted996 $18   2,451 $17   54 $21   
Exercised(2,213)$14   (2,429)$13   (10,644)$13   
Forfeited/cancelled/expired(239)$19   (15)$10   (391)$16   
Outstanding at end of year5,637 $17 6.4$10 7,093 $16 5.7$15 7,086 $14 4.2$73 
Vested and expected to vest5,637 $17 6.4$10 7,093 $16 5.7$15 7,084 $14 4.2$73 
Exercisable3,196 $15 4.4$4,707 $14 3.6$15 4,707 $14 3.7$49 
Schedule of Shares Available for Future Grant and Shares Reserved for Future Issuance
Shares available for future grant and shares reserved for future issuance under the stock-based incentive compensation plans and the 2011 ESPP were as follows:
 As of October 31
 202020192018
 In thousands
Shares available for future grant229,334 265,135 305,767 
Shares reserved for future issuance264,110 301,608 343,076